A randomized placebo-controlled double-blinded trial of the treatment of MRSA throat carriage with either standard decolonization therapy or standard decolonization therapy combined with oral clindamycin

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516377-69-01

Enrollment

Registered

2024-10-23

Start date

Unknown

Completion date

2025-08-31

Last updated

2025-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRSA throat carriage

Brief summary

MRSA negative swabs at 1 months

Detailed description

MRSA negative swabs after 6 months

Interventions

DRUGCLINDAMYCIN

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
MRSA negative swabs at 1 months	—

Secondary

Measure	Time frame
MRSA negative swabs after 6 months	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026